
Innovations in care and research
With more than 50 distinguished clinical and research faculty members, we offer the region’s most leading-edge care and research breakthroughs. We also are committed to training the future leaders of our specialty through our nationally ranked residency and fellowship training programs.
U.S. News & World Report ranks Ohio State among the best hospitals in the nation for gynecology, which is ranked 46th.
Read about the latest clinical and research innovations taking place in the Department of Obstetrics and Gynecology.
Featured Stories


Two faculty members shine in their commitment to gynecologic oncology research

Literature review makes the case for broadening oxygen saturation targets for pregnant individuals hospitalized with COVID-19

Researchers take next steps to understand COVID-19’s impact on people infected during pregnancy

LACC wasn’t the last word on minimally invasive surgery for early-stage cervical cancer

Helping patients experience the best reproductive health possible, from birth to early adulthood

Changing the standard of care for uterine cancer

William Grobman, MD, joins The Ohio State University Wexner Medical Center

Branching out and looking within to improve prenatal, postpartum care

Exploring new immunotherapy treatment for high-risk endometrial cancer patients

Ohio State strives to improve inclusion of pregnant women in COVID-19 and other therapeutics research

Ohio State studies use of opioids following cesarean section

Improving care for menopausal women across all specialties

Ohio State Researchers Reveal Promising Cervical Cancer Treatment

Unique Multidisciplinary Care for Pregnancy-Related Pelvic Floor Disorders

Complex Contraception Clinic and Personalized Contraception Counseling

Researchers Aim to Identify Molecular-Based Risk Factors for Endometrial Cancer

Study Suggests Laser Therapy Can Improve Quality of Life for Cancer Survivors With GSM

Obstetrics and Gynecology Residency Program Launching Global Health Elective

New Maternal Fetal Medicine Division Director Brings National Study to Ohio State

Ohio State Experts Lead Pilot Program to Change Maternal Hypertension Guidelines

TILs Trial Promising as a Therapy for Recurrent, Metastatic or Persistent Cervical Cancer

PARP Inhibitors Dramatically Improve Outlook for Ovarian Cancer Patients

Ohio State Study Examines Link Between Hormonal Contraception and Depression

STEPP Clinic Offers Addiction Lifeline During Pregnancy

Leading the way